New hope for controlling devastating seizures in rare genetic disorder
Disease control
Ongoing
This study is testing whether adding the medication ZX008 (fenfluramine) to existing treatments can better control seizures in people with CDKL5 deficiency disorder, a rare genetic condition that causes severe epilepsy and developmental delays. The trial involves children and adu…
Phase: PHASE3 • Sponsor: Zogenix, Inc. • Aim: Disease control
Last updated Apr 02, 2026 05:27 UTC